MCP -- Table of Contents (April, 2004); 3 [4])

Editorial

Cancer Proteomics

Julio E. Celis
Mol Cell Proteomics 2004: 297
[Full Text] [PDF]

Reviews/Perspectives

HUPO Initiatives Relevant to Clinical Proteomics

Sam Hanash
Mol Cell Proteomics 2004: 298–301 First Published on January 27, 2004 doi:10.1074/mcp.R400004-MCP200
[Abstract] [Full Text] [PDF]

Clinical Infrastructures to Support Proteomic Studies of Tissue and Fluids in Breast Cancer

Henning T. Mouridsen and Nils Brünner
Mol Cell Proteomics 2004: 302–310 First Published on February 3, 2004 doi:10.1074/mcp.R400003-MCP200
[Abstract] [Full Text] [PDF]

Progress and Challenges in Screening for Early Detection of Ovarian Cancer

Ian J. Jacobs and Usha Menon
Mol Cell Proteomics 2004: 355–366 First Published on February 5, 2004 doi:10.1074/mcp.R400006-MCP200
[Abstract] [Full Text] [PDF]

Mass Spectrometry as a Diagnostic and a Cancer Biomarker Discovery Tool: Opportunities and Potential Limitations

Eleftherios P. Diamandis
Mol Cell Proteomics 2004: 367–378 First Published on February 28, 2004 doi:10.1074/mcp.R400007-MCP200
[Abstract] [Full Text] [PDF]

Targeted Therapy in Breast Cancer: The HER-2/neu Gene and Protein

Jeffrey S. Ross, Jonathan A. Fletcher, Kenneth J. Bloom, Gerald P. Linette, James Stec, W. Fraser Symmans, Lajos Pusztai, and Gabriel N. Hortobagyi
Mol Cell Proteomics 2004: 379–398 First Published on February 3, 2004 doi:10.1074/mcp.R400001-MCP200
[Abstract] [Full Text] [PDF]

Research

The Human Plasma Proteome: A Nonredundant List Developed by Combination of Four Separate Sources

N. Leigh Anderson, Malu Polanski, Rembert Pieper, Tina Gatlin, Radhakrishna S. Tirumalai, Thomas P. Conrads, Timothy D. Veenstra, Joshua N. Adkins, Joel G. Pounds, Richard Fagan, and Anna Lobley
Mol Cell Proteomics 2004: 311–326 First Published on January 12, 2004 doi:10.1074/mcp.M300127-MCP200
[Abstract] [Full Text] [PDF] [Supplemental Data]

Proteomic Characterization of the Interstitial Fluid Perfusing the Breast Tumor Microenvironment: A Novel Resource for Biomarker and Therapeutic Target Discovery

Julio E. Celis, Pavel Gromov, Teresa Cabezón, José M. A. Moreira, Noona Ambartsumian, Kerstin Sandelin, Fritz Rank, and Irina Gromova
Mol Cell Proteomics 2004: 327–344 First Published on January 30, 2004 doi:10.1074/mcp.M400009-MCP200
[Abstract] [Full Text] [PDF]

How Industry Is Approaching the Search for New Diagnostic Markers and Biomarkers

J. Werner Zolg and Hanno Langen
Mol Cell Proteomics 2004: 345–354 First Published on January 28, 2004 doi:10.1074/mcp.M400007-MCP200
[Abstract] [Full Text] [PDF]

Accurate Qualitative and Quantitative Proteomic Analysis of Clinical Hepatocellular Carcinoma Using Laser Capture Microdissection Coupled with Isotope-coded Affinity Tag and Two-dimensional Liquid Chromatography Mass Spectrometry

Chen Li, Yi Hong, Ye-Xiong Tan, Hu Zhou, Jian-Hua Ai, Su-Jun Li, Lei Zhang, Qi-Chang Xia, Jia-Rui Wu, Hong-Yang Wang, and Rong Zeng
Mol Cell Proteomics 2004: 399–409 First Published on January 15, 2004 doi:10.1074/mcp.M300133-MCP200
[Abstract] [Full Text] [PDF]

Expression of the Tumor Suppressor Protein 14-3-3 ${sigma}$ Is Down-regulated in Invasive Transitional Cell Carcinomas of the Urinary Bladder Undergoing Epithelial-to-Mesenchymal Transition

José M. A. Moreira, Pavel Gromov, and Julio E. Celis
Mol Cell Proteomics 2004: 410–419 First Published on January 21, 2004 doi:10.1074/mcp.M300134-MCP200
[Abstract] [Full Text] [PDF]

Information

Calendar

Mol Cell Proteomics 2004: 420–421
[Full Text] [PDF]